Kemi - Ångström part of the University award "Attractive Innovation Project Awards 2019"

2019-12-19

15 projects run by, or in collaboration with, Uppsala University researchers and students have been acknowledged with the 2019 "Attractive Innovation Project" award. Common to all projects is support från Uppsala University Innovation and success in securing external funding to further enhance development opportunities.

It is professor Jöns Hilborn together with Polymer Chemistry colleague Oommen Varghese that receives the award for their project named Uppsala Therapeutics.

The motivation is as follows:

Uppsala Therapeutics – redesigning existing technology to create conditions for new drugs

There are still a number of diseases for which treatment options are very limited, or where there are no alternatives. Many of these could benefit from drugs based on so-called RNA interference, with which harmful or erroneous proteins can be reduced. Unfortunately, it has been difficult to turn the technology into useful drugs. Uppsala Therapeutics has developed a new design of the interfering RNA molecules that solves many of the previous problems. The company is founded by Jöns Hillborn and Oommen Varghese, both researchers in polymer chemistry at the Department of Chemistry – Ångström Laboratory, together with Oommen P Oommen at Tampere University and Victor Hartman who is the company’s CEO. The researchers received funding through Vinnova's VFT+ programme in order to further develop the solution commercially.

Congratulations Jöns and Oommen!

Read the entire article at Uppsala University central webpage

Fler nyheter

Kemi - Ångström part of the University award "Attractive Innovation Project Awards 2019"

2019-12-19

15 projects run by, or in collaboration with, Uppsala University researchers and students have been acknowledged with the 2019 "Attractive Innovation Project" award. Common to all projects is support från Uppsala University Innovation and success in securing external funding to further enhance development opportunities.

It is professor Jöns Hilborn together with Polymer Chemistry colleague Oommen Varghese that receives the award for their project named Uppsala Therapeutics.

The motivation is as follows:

Uppsala Therapeutics – redesigning existing technology to create conditions for new drugs

There are still a number of diseases for which treatment options are very limited, or where there are no alternatives. Many of these could benefit from drugs based on so-called RNA interference, with which harmful or erroneous proteins can be reduced. Unfortunately, it has been difficult to turn the technology into useful drugs. Uppsala Therapeutics has developed a new design of the interfering RNA molecules that solves many of the previous problems. The company is founded by Jöns Hillborn and Oommen Varghese, both researchers in polymer chemistry at the Department of Chemistry – Ångström Laboratory, together with Oommen P Oommen at Tampere University and Victor Hartman who is the company’s CEO. The researchers received funding through Vinnova's VFT+ programme in order to further develop the solution commercially.

Congratulations Jöns and Oommen!

Read the entire article at Uppsala University central webpage